09 Feb 2024 --- A recent human clinical trial reveals that Gencor’s palmitoylethanolamide (PEA) ingredient, Levagen+, can help alleviate the discomfort associated with migraine headaches. The study also found that Levagen+ may reduce the duration of migraines in healthy individuals.
